featured
Neoadjuvant Nivolumab Plus Ipilimumab vs Adjuvant Nivolumab in Stage III Melanoma: NADINA
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: